Pulse Biosciences, Inc. PLSE Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$18.58M-6.6% | -$17.43M+10.1% | -$19.39M-1.1% | -$19.17M-14.1% | -$16.8M+13.4% | ||
| $88K-5.4% | $93K-7.0% | $100K0.0% | $100K-14.5% | $117K-3.3% | ||
| $1.91M-61.5% | $4.97M-11.5% | $5.62M+8.2% | $5.19M-8.7% | $5.68M-16.4% | ||
| -$55K-121% | $259K— | —— | —— | $0— | ||
| $70K-11.4% | $79K+1,217% | $6K-71.4% | $21K-30.0% | $30K— | ||
| -$148K— | —— | $274K-17.5% | $332K-53.4% | $712K+10,271% | ||
| $1.83M+213% | -$1.63M— | —— | —— | -$3.04M-195% | ||
| -$3K— | —— | —— | $422K+42,100% | $1K-96.8% | ||
| -$62K— | —— | —— | —— | $0— | ||
| $167K+0.6% | $166K0.0% | $166K-0.6% | $167K+0.6% | $166K0.0% | ||
| $308K+0.7% | $306K+5.2% | $291K+3.2% | $282K+2.9% | $274K+7.5% | ||
| -$375K-4.2% | -$360K-1.4% | -$355K-6.9% | -$332K-3.4% | -$321K-7.4% | ||
| -$14.6M+1.1% | -$14.76M-13.2% | -$13.04M-1.8% | -$12.81M+5.3% | -$13.52M-47.9% | ||
| $33K-68.6% | $105K+69.4% | $62K-39.8% | $103K+129% | $45K-15.1% | ||
| -$33K+68.6% | -$105K-69.4% | -$62K+49.6% | -$123K-173% | -$45K+15.1% | ||
| $1.67M+333% | $387K-77.3% | $1.71M+14,133% | $12K-96.8% | $380K+1.9% | ||
| $2.21M+481% | $381K-80.6% | $1.97M— | $0-100% | $14.81M-69.3% | ||
| -$12.42M+14.2% | -$14.48M-30.0% | -$11.14M+13.9% | -$12.93M-1,142% | $1.24M-96.8% | ||
| $167K+0.6% | $166K0.0% | $166K-0.6% | $167K+0.6% | $166K0.0% | ||
| $88K-5.4% | $93K-7.0% | $100K0.0% | $100K-14.5% | $117K-3.3% | ||
| -$375K-4.2% | -$360K-1.4% | -$355K-6.9% | -$332K-3.4% | -$321K-7.4% | ||
| $129K-65.5% | $374K+225% | $115K-19.0% | $142K-49.5% | $281K— | ||
| $308K+0.7% | $306K+5.2% | $291K+3.2% | $282K+2.9% | $274K+7.5% | ||
| -$62K— | —— | —— | —— | $0— | ||
| $57K— | $0— | $0— | $0— | $0-100% | ||
| $465K— | —— | $241K— | —— | $352K— | ||
| $130K+550% | $20K+17.6% | $17K— | $0-100% | $14.08M-70.6% | ||
| $28K— | —— | —— | —— | $26K— | ||
| -$375K-4.2% | -$360K-1.4% | -$355K-6.9% | -$332K-3.4% | -$321K-7.4% | ||
| —— | $0— | $0— | $0— | $0-100% | ||
| $111K— | —— | —— | —— | $0— | ||
| $3K— | —— | —— | —— | $11K+238% | ||
| $281K— | —— | —— | —— | $0— | ||
| -$14.63M+1.6% | -$14.86M-13.4% | -$13.1M-1.5% | -$12.91M+4.8% | -$13.57M-47.5% | ||
| -$14.63M+1.6% | -$14.86M-13.4% | -$13.1M-1.5% | -$12.91M+4.8% | -$13.57M-47.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Pulse Biosciences, Inc. generate?
- Pulse Biosciences, Inc. (PLSE) generated -$55.2M in operating cash flow over the trailing twelve months.
- What is Pulse Biosciences, Inc.'s free cash flow?
- After $303.0K of capital expenditures, Pulse Biosciences, Inc.'s free cash flow was -$55.5M over the trailing twelve months, down 37.9% year over year.
- Where does Pulse Biosciences, Inc.'s cash flow data come from?
- Every line is extracted from Pulse Biosciences, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
